Global cerebral atrophy after subarachnoid hemorrhage: A possible marker of acute brain injury and assessment of its impact on outcome

Acta Neurochirurgica, Supplementum

Volumn 115, Issue , 2013, Pages 17-21

  Tam, Alan K H ^a   Ilodigwe, Don ^b,c   Li, Zeyu ^b,c   Schweizer, Tom A ^b,c   Macdonald, R Loch ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain atrophy; CONSCIOUS; Outcome; Subarachnoid hemorrhage

Indexed keywords

CLAZOSENTAN;

ADULT; ARTIFACT; BODY TEMPERATURE; BRAIN ATROPHY; BRAIN INJURY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; GLOBAL BRAIN ATROPHY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; VOXEL BASED MORPHOMETRY;

EID: 85052609600     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1192-5_5     Document Type: Conference Paper

References (13)

1. Bendel P, Koivisto T, Aikia M, Niskanen E, Kononen M, Hanninen T, Vanninen R (2010) Atrophic enlargement of CSF volume after subarachnoid hemorrhage: Correlation with neuropsychological outcome. AJNR 31:370-3766
2. Bendel P, Koivisto T, Niskanen E, Kononen M, Aikia M, Hanninen T, Koskenkorva P, Vanninen R (2009) Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: A voxel-based morphometric study. Neuroradiology 51:711-7222
3. Biessels GJ, Koffeman A, Scheltens P (2006) Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 253:477-4822
4. Hadjivassiliou M, Tooth CL, Romanowski CA, Byrne J, Battersby RD, Oxbury S, Crewswell CS, Burkitt E, Stokes NA, Paul C, Mayes AR, Sagar HJ (2001) Aneurysmal SAH: Cognitive outcome and structural damage after clipping or coiling. Neurology 56:1672-16777
5. Lin X, Blumhardt LD (2001) In fl ammation and atrophy in multiple sclerosis: MRI associations with disease course. J Neurol Sci 189:99-1044
6. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, doubleblind, placebo-controlled phase 2 dose- fi nding trial. Stroke 39: 3015-30211
7. Pobereskin LH (2001) Incidence and outcome of subarachnoid haemorrhage: A retrospective population based study. JNNP 70:340-3433
8. Salerno JA, Murphy DG, Horwitz B, DeCarli C, Haxby JV, Rapoport SI, Schapiro MB (1992) Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 20:340-3488
9. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC (1999) Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS investigators. Stroke 30:293-2988
10. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC (2003) A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 60:989-9944
11. Tam AK, Ilodigwe D, Mocco J, Mayer S, Kassell N, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL (2010) Impact of systemic in fl ammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: Exploratory analysis of CONSCIOUS-1 database. Neurocrit Care 13:182-1899
12. Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 42:924-9299
13. Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer M, Hussein S, Durfee J, Ramanathan M (2009) Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 73:504-5100